Page last updated: 2024-08-25

selfotel and Cerebrovascular Disorders

selfotel has been researched along with Cerebrovascular Disorders in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bullock, R	1
Albers, GW; Davis, SM; Diener, HC; Lees, KR; Norris, J	1
Löscher, W; Szabo, L; Wlaź, P	1
Choi, DW; Zivin, JA	1

Reviews

1 review(s) available for selfotel and Cerebrovascular Disorders

Article	Year
Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies. Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765 Topics: Brain; Brain Injuries; Cerebrovascular Disorders; Clinical Trials as Topic; Craniocerebral Trauma; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Pipecolic Acids	1995

Article

Year

Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies.

Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765

Topics: Brain; Brain Injuries; Cerebrovascular Disorders; Clinical Trials as Topic; Craniocerebral Trauma; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Pipecolic Acids

1995

Trials

2 trial(s) available for selfotel and Cerebrovascular Disorders

Article	Year
Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044 Topics: Aged; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Pipecolic Acids; Treatment Outcome	1997
Stroke therapy. Scientific American, 1991, Volume: 265, Issue:1 Topics: Animals; Arterial Occlusive Diseases; Calcium; Cell Survival; Cerebral Arterial Diseases; Cerebrovascular Disorders; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Intracranial Embolism and Thrombosis; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Tissue Plasminogen Activator; Tomography, Emission-Computed	1991

Article

Year

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed.

Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044

Topics: Aged; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Pipecolic Acids; Treatment Outcome

1997

Stroke therapy.

Scientific American, 1991, Volume: 265, Issue:1

Topics: Animals; Arterial Occlusive Diseases; Calcium; Cell Survival; Cerebral Arterial Diseases; Cerebrovascular Disorders; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Intracranial Embolism and Thrombosis; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Tissue Plasminogen Activator; Tomography, Emission-Computed

1991

Other Studies

1 other study(ies) available for selfotel and Cerebrovascular Disorders

Article	Year
Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats. Neuroscience letters, 1998, Jan-02, Volume: 240, Issue:1 Topics: Animals; Behavior, Animal; Binding, Competitive; Brain; Brain Ischemia; Cerebrovascular Disorders; Dizocilpine Maleate; Injections, Intraperitoneal; Male; Pipecolic Acids; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate	1998

Article

Year

Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats.

Neuroscience letters, 1998, Jan-02, Volume: 240, Issue:1

Topics: Animals; Behavior, Animal; Binding, Competitive; Brain; Brain Ischemia; Cerebrovascular Disorders; Dizocilpine Maleate; Injections, Intraperitoneal; Male; Pipecolic Acids; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate

1998